Pfizer Inc. Company Summary |
|
Pfizer Inc.(NASDAQ: PFE). The Group's principal activities are to discover, develop, manufacture and market prescription medicines for humans and animals as well as many of the world's best-known consumer products. The Group operates in two business segments pharmaceuticals and consumer products. Pharmaceuticals segment includes prescription pharmaceuticals for treating cardiovascular diseases, infectious diseases, central nervous system disorders, diabetes, erectile dysfunction, allergies, arthritis and other disorders. The major revenue generating pharmaceutical products are Lipitor, Norvasc, Cardura, Accupril, Zithromax, Viracept, Zoloft, Neurontin, Viagra and Zyrtec. Consumer products segment includes consumer health care products, confectionery products, shaving products and tetra fish products. Pharmaceutical products accounted for 84% of 2001 revenues and consumer products, 16%.
|
|
COMPANY DATA |
 |
Principal Sector |
Gesundheit & Pharm General |
 |
|
Principal Industry |
Healthcare |
|
|
Homepage |
www.pfizer.com |
|
| |
Key Developments: Pfizer Inc.
 |
Australischer Marktbericht, 20. Dezember 2010: IMX Resources (ASX:IXR) verschiffte erste Eisen-Kupfer-Erz Lieferung nach China
DEC 20, 2010 13:30 - Article Views: 1,540
Australischer Marktbericht, 20. Dezember 2010 beinhaltet: IMX Resources (ASX:IXR) verschiffte erste Eisen-Kupfer-Erz Lieferung nach China; Phylogica Limited (ASX:PYC) unterzeichnete Kooperations- und Lizenzvereinbarung mit Pfizer (NYSE:PFE); Copper Strike Limited (ASX:CSE) berichtet über starke Kupfer/Silber/Kobalt Resultate aus dem Walford Creek Projekt in Nordwest Queensland; Die südamerikanische Ferro Metals Limited (ASX:SFZ) aus Brasilien produzierte mehr als 400.000 Tonnen Eisenerz. |
|
25,789 COMPANY PROFILE VIEWS |
|
Diese Seite wurde besucht: (letzten 7 Tagen: 14) (letzten 30 Tagen: 67) (seit Veröffentlichung: 1122)
|
|
|
|
